Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit® S 100 Coating on the In Vitro Drug Release
Authors:
- Sateesh Kumar VemulaSateesh Kumar Vemula
- Sagar NaralaSNSagar Narala
- Prateek UttrejaPUPrateek Uttreja
- Nagarjuna NaralaNNNagarjuna Narala
- Bhaskar DaravathBDBhaskar Daravath
- Chamundeswara Srinivasa Akash KallaCKChamundeswara Srinivasa Akash Kalla
- Srikanth BaisaSBSrikanth Baisa
- Siva Ram MunnangiSMSiva Ram Munnangi
- Naveen ChellaNaveen Chella
- Michael A. RepkaMichael A. Repka
Open Access
- 27 September 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (10) , 1265
Abstract
Background: A pelletizer paired with hot-melt extrusion technology (HME) was used to develop colon-targeted pellets for ketoprofen (KTP). Thermal stability and side effects in the upper gastrointestinal tract made ketoprofen more suitable for this work. Methods: The pellets were prepared using the enzyme-triggered polymer Pectin LM in the presence of HPMC HME 4M, followed by pH-dependent Eudragit® S 100 coating to accommodate the maximum drug release in the colon by minimizing drug release in the upper gastrointestinal tract (GIT). Box–Behnken Design (BBD) was used for response surface optimization of the proportion of different independent variables like Pectin LM (A), HPMC HME 4M (B), and Eudragit® S 100 (C) required to lower the early drug release in upper GIT and to extend the drug release in the colon. Results: Solid-state characterization studies revealed that ketoprofen was present in a solid solution state in the hot-melt extruded polymer matrix. The desired responses of the prepared optimized KTP pellets obtained by considering the designed space showed 1.20% drug release in 2 h, 3.73% in the first 5 h of the lag period with the help of Eudragit® S 100 coating, and 93.96% in extended release up to 24 h in the colonic region. Conclusions: Hence, developing Eudragit-coated hot-melt extruded pellets could be a significant method for achieving the colon-specific release of ketoprofen.Keywords
This publication has 32 references indexed in Scilit:
- Optimizing Entrectinib Nanosuspension: Quality by Design for Enhanced Oral Bioavailability and Minimized Fast-Fed VariabilityBioNanoScience, 2024
- Quality by design (QbD) approach to develop fast-dissolving tablets using melt-dispersion paired with surface-adsorption method: formulation and pharmacokinetics of flurbiprofen melt-dispersion granulesDrug Delivery and Translational Research, 2023
- Recent advances in colon drug delivery systemsJournal of Controlled Release, 2020
- Pectin polymers for colon-targeted antitumor drug deliveryInternational Journal of Biological Macromolecules, 2020
- A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug releaseInternational Journal of Pharmaceutics, 2020
- Development of vildagliptin loaded Eudragit® microspheres by screening design: in vitro evaluationJournal of Pharmaceutical Investigation, 2017
- Optimization of the Büchi B-90 spray drying process using central composite design for preparation of solid dispersionsInternational Journal of Pharmaceutics, 2015
- Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamineInternational Journal of Pharmaceutics, 2015
- Influence of pectin properties and processing conditions on thermal pectin degradationFood Chemistry, 2007
- An Investigation into the In Vivo Performance Variability of pH Responsive Polymers for Ileo-Colonic Drug Delivery Using Gamma Scintigraphy in HumansJournal of Pharmaceutical Sciences, 2006